Related Experiment Video
Updated: Nov 21, 2025
11:20
Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
Published on: May 12, 2020
6.8K
Bacteriophage therapy for infections in CF
Benjamin K Chan1, Gail Stanley2, Mrinalini Modak3
1Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut, USA.
Pediatric Pulmonology
|January 12, 2021
Summary
Bacteriophage therapy shows promise for treating antibiotic-resistant lung infections in cystic fibrosis (CF) patients. Further research is needed to optimize phage treatments and predict efficacy against bacterial pathogens like Pseudomonas aeruginosa and Staphylococcus aureus.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Pseudomonas aeruginosa and Staphylococcus aureus are key pathogens in cystic fibrosis (CF) lung infections.
- Increasing antibiotic resistance in these bacteria necessitates alternative treatment strategies.
- Bacteriophage (phage) therapy offers a potential solution by using viruses that specifically infect and kill bacteria.
Purpose of the Study:
- To review the renewed interest and potential of phage therapy for antibiotic-resistant bacterial infections in CF.
- To highlight the importance of rigorous data collection and analysis for assessing clinical benefits.
- To identify areas for further basic research in phage therapy efficacy and application.
Main Methods:
- Review of recent case reports and publications on phage therapy in CF patients.
- Discussion of the principles of lytic phage therapy against bacterial pathogens.
- Emphasis on the need for clinical trial data and basic research for optimization.
Main Results:
- Recent case reports demonstrate the clinical application of phage therapy for antibiotic-resistant CF lung infections.
- Phage therapy is gaining attention as a viable alternative to antibiotics.
- Further research is required to understand phage-pathogen interactions and optimize treatment protocols.
Conclusions:
- Phage therapy presents a promising avenue for managing antibiotic-resistant infections in cystic fibrosis.
- Clinical trials and basic research are crucial for validating and refining phage therapy strategies.
- Understanding phage efficacy with different administration methods (alone, sequential, cocktails) is essential for successful patient treatment.
Related Concept Videos
01:30Lytic Cycle of Bacteriophages
75.0K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
75.0K
01:24Cystic Fibrosis: Management
316
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
316
01:26DNA Bacteriophages
441
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
441
01:23Cystic Fibrosis: Pathogenesis
556
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
556
00:43Lysogenic Cycle of Bacteriophages
65.8K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
65.8K
01:16Viral Replication: Lysogenic Cycle
832
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
832